Capital International Investors 13D/13G Filings for Allogene Therapeutics, Inc. (ALLO)

Capital International Investors 13D and 13G filings for Allogene Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
11:19 am
Sale		 2022-02-14 13G Allogene Therapeutics, Inc.
ALLO		 Capital International Investors 1,728,252
1.200%		 -5,971,451decrease
(-77.55%)		 Filing
2021-02-16
4:04 pm
Purchase		 2021-02-16 13G Allogene Therapeutics, Inc.
ALLO		 Capital International Investors 7,699,703
5.500%		 7,699,703increase
(New Position)		 Filing